As of mid-August 2026, extensive CDC and WHO surveillance shows SARS-CoV-2 activity remains low and stable globally, with positive test rates around 3.4%, very low emergency department visits (0.3%), and minimal hospitalizations, reflecting endemic circulation of Omicron descendants rather than pandemic conditions. Monitored variants such as BA.3.2 (Cicada) and XFG exhibit limited immune escape and no evidence of substantially increased transmissibility or severity relative to recent strains. This sustained low burden, following the virus’s transition to endemicity, underpins traders’ 96.3% implied probability of no new coronavirus pandemic. A realistic shift could occur only if genomic surveillance detects a novel, highly virulent strain with rapid community spread capable of overwhelming health systems before year-end.